More to consider with Cancer Genetics, Inc.
/What’s at Stake for Cancer Genetics, Inc. (NasdaqCM:CGIX)? Cash Flow Change of -1.00000 Tells a Story
Cancer Genetics, Inc. (NasdaqCM:CGIX) has seen year over year cash flow change of -1.00000. This is calculated as the one year percentage growth of the firm’s cash flow from operations from their publicly filed statement of cash flows. Cash reserves are an important element for an investor to consider when analyzing a stock. A continued reduction in cash flow could spell trouble for a firm while on the other hand solid continued cash flow growth should translate into stock growth.
